BG
AHCO icon

Bollard Group’s AdaptHealth AHCO Stock Holding History

Bollard Group’s Portfolio AHCO Stock Details AHCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-316
Closed -$4K – 362
2023
Q2 		$4K Buy
+316
New +$3.52K ﹤0.01% 416

Other funds holding AHCO

OCA
OEP Capital Advisors New York $194M AUM 9.78% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
SkyKnight Capital San Francisco, California $107M AUM 9.69% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $74.2B AUM 21.09% 1-Year Est. Return
RP
Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

Bollard Group's AHCO Position: Q3 2023 in Review

Bollard Group sold out of AdaptHealth (AHCO) in Q3 2023, closing a stake of 316 shares — an estimated $4K sold.

Bollard Group first reported a position in AHCO in Q2 2023 and held it in 1 quarter. The position peaked at $4K in Q2 2023. 191 funds tracked by Wall St. Rank hold AHCO as of Q3 2023.

  • Bollard Group reported no remaining AdaptHealth position as of Q3 2023 after selling out during the quarter.
  • Bollard Group sold 316 AdaptHealth shares in Q3 2023, an estimated $4K.
  • Bollard Group first reported a position in AdaptHealth in Q2 2023 and held it in 1 quarter.
  • Bollard Group's AdaptHealth position peaked at $4K in Q2 2023.
  • 191 funds tracked by Wall St. Rank held AdaptHealth as of Q3 2023.

Based on Bollard Group's 13F filing for Q3 2023, filed 14 Nov 2023.